Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Navidea Biopharmaceuticals Names Craig A. Dais As CFO

Author: Benzinga Newsdesk | July 27, 2023 04:23pm

Craig A. Dais will report directly to the Company's Chief Medical Officer. Dais's hiring aligns with the Company's stated objectives and its Fix, Fund, Propel approach to advancing innovative technology to market.

Posted In: NAVB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist